Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism
Authors
Keywords
-
Journal
JOURNAL OF ETHNOPHARMACOLOGY
Volume 296, Issue -, Pages 115478
Publisher
Elsevier BV
Online
2022-06-16
DOI
10.1016/j.jep.2022.115478
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liver biopsy for assessment of chronic liver diseases: a synopsis
- (2022) Aqib B. Chowdhury et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Phillygenin Protects the Intestinal Barrier from Dysfunction via let-7b Signaling Pathway and Regulation of Intestinal Microbiota
- (2022) Huiping Feng et al. Journal of Healthcare Engineering
- The roles and mechanisms of hypoxia in liver fibrosis
- (2021) Jingyao Cai et al. Journal of Translational Medicine
- Butyrate Protects against Diet-Induced NASH and Liver Fibrosis and Suppresses Specific Non-Canonical TGF-β Signaling Pathways in Human Hepatic Stellate Cells
- (2021) Eveline Gart et al. Biomedicines
- The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
- (2020) Ygor Parladore Silva et al. Frontiers in Endocrinology
- Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial–Mesenchymal Transition in Pancreatic Cancer Cells
- (2020) Hongchun Li et al. OncoTargets and Therapy
- Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
- (2020) Natascha Roehlen et al. Cells
- Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism
- (2020) Jin He et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Short chain fatty acids in human gut and metabolic health
- (2020) E.E. Blaak et al. Beneficial Microbes
- Phillygenin exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes
- (2019) Bingyuan Du et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
- (2019) Wenhao Li et al. Acta Pharmaceutica Sinica B
- Probiotic LGG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice
- (2019) Yunhuan Liu et al. HEPATOLOGY
- Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases
- (2019) Er-teng Jia et al. Journal of Zhejiang University-SCIENCE B
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway
- (2019) Naihua Hu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Bile Acid Metabolism in Liver Pathobiology
- (2018) John Y. L. Chiang et al. GENE EXPRESSION
- Phytochemistry, pharmacology, quality control and future research of Forsythia suspensa (Thunb.) Vahl: A review
- (2018) Zhaoyi Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Liver fibrosis
- (2018) M. Merve Aydin et al. Turkish Journal of Gastroenterology
- Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
- (2018) Maurizio Parola et al. MOLECULAR ASPECTS OF MEDICINE
- Evaluation of the Pharmacokinetics and Hepatoprotective Effects of Phillygenin in Mouse
- (2018) Wei Song et al. Biomed Research International
- ANNALS EXPRESS: Bile acids and the metabolic syndrome
- (2018) Emma Rose McGlone et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Combined obeticholic acid and apoptosis inhibitor treatment alleviates liver fibrosis
- (2018) Jiyu Zhou et al. Acta Pharmaceutica Sinica B
- Effects of exogenous thymosin β4 on carbon tetrachloride-induced liver injury and fibrosis
- (2017) Xiankui Li et al. Scientific Reports
- Interaction of gut microbiota with bile acid metabolism and its influence on disease states
- (2016) Christopher Staley et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- The Intestinal Immune System in Obesity and Insulin Resistance
- (2016) Daniel A. Winer et al. Cell Metabolism
- Diet, microorganisms and their metabolites and colon cancer
- (2016) Stephen J. D. O'Keefe Nature Reviews Gastroenterology & Hepatology
- Fatty liver diseases, bile acids, and FXR
- (2016) Yan Zhu et al. Acta Pharmaceutica Sinica B
- Recent advancement of molecular mechanisms of liver fibrosis
- (2015) Ekihiro Seki et al. Journal of Hepato-Biliary-Pancreatic Sciences
- The carbon tetrachloride model in mice
- (2015) D Scholten et al. LABORATORY ANIMALS
- Reversibility of liver fibrosis
- (2015) Mengxi Sun et al. Clinics and Research in Hepatology and Gastroenterology
- Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate†
- (2009) Kimberley Lewis et al. INFLAMMATORY BOWEL DISEASES
- Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell Monolayers
- (2009) Luying Peng et al. JOURNAL OF NUTRITION
- Lignans from the Fruits ofForsythia suspensa(Thunb.) Vahl Protect High-Density Lipoprotein during Oxidative Stress
- (2008) Min-Jung CHANG et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started